These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 9009643)
1. Microsporum canis infections in children: results of a new oral antifungal therapy. Ginter G Mycoses; 1996; 39(7-8):265-9. PubMed ID: 9009643 [TBL] [Abstract][Full Text] [Related]
2. Systemic antifungal therapy for tinea capitis in children. Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C; Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378 [TBL] [Abstract][Full Text] [Related]
4. Systemic antifungal therapy for tinea capitis in children. González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825 [TBL] [Abstract][Full Text] [Related]
5. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692 [TBL] [Abstract][Full Text] [Related]
7. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole. Möhrenschlager M; Schnopp C; Fesq H; Strom K; Beham A; Mempel M; Thomsen S; Brockow K; Wessner DB; Heidelberger A; Ruhdorfer S; Weigl L; Seidl HP; Ring J; Abeck D Br J Dermatol; 2000 Nov; 143(5):1011-5. PubMed ID: 11069511 [TBL] [Abstract][Full Text] [Related]
8. Itraconazole is effective in the treatment of tinea capitis caused by Microsporum canis. Gupta AK; Ginter G Pediatr Dermatol; 2001; 18(6):519-22. PubMed ID: 11841643 [TBL] [Abstract][Full Text] [Related]
9. Guidelines for the management of tinea capitis in children. Kakourou T; Uksal U; Pediatr Dermatol; 2010; 27(3):226-8. PubMed ID: 20609140 [TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes for tinea capitis in a skin of color population. Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228 [TBL] [Abstract][Full Text] [Related]
11. The use of itraconazole to treat cutaneous fungal infections in children. Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406 [TBL] [Abstract][Full Text] [Related]
12. Griseofulvin and terbinafine in the treatment of tinea capitis in children. Rademaker M; Havill S N Z Med J; 1998 Feb; 111(1060):55-7. PubMed ID: 9539918 [TBL] [Abstract][Full Text] [Related]
13. [Tinea capitis. Therapeutic options in the post-griseofulvin era]. Möhrenschlager M; Korting HC; Seidl HP; Ring J; Abeck D Hautarzt; 2002 Dec; 53(12):788-94. PubMed ID: 12444518 [TBL] [Abstract][Full Text] [Related]
14. Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children. López-Gómez S; Del Palacio A; Van Cutsem J; Soledad Cuétara M; Iglesias L; Rodriguez-Noriega A Int J Dermatol; 1994 Oct; 33(10):743-7. PubMed ID: 8002149 [TBL] [Abstract][Full Text] [Related]
15. Tinea capitis in children: a systematic review of management. Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669 [TBL] [Abstract][Full Text] [Related]
16. Tinea capitis caused by Microsporum canis treated with terbinafine. Aste N; Pau M Mycoses; 2004 Oct; 47(9-10):428-30. PubMed ID: 15504128 [TBL] [Abstract][Full Text] [Related]
17. Tinea capitis caused by Microsporum canis: A case study of three family members in India, a non-endemic region. Capoor MR; Sharma S; Goenka S; Das S; Rudramurthy SM; Khunger N; Kamra N Indian J Med Microbiol; 2024; 50():100621. PubMed ID: 38885904 [TBL] [Abstract][Full Text] [Related]
18. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks. Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040 [TBL] [Abstract][Full Text] [Related]
19. Tinea capitis: an overview with emphasis on management. Gupta AK; Hofstader SL; Adam P; Summerbell RC Pediatr Dermatol; 1999; 16(3):171-89. PubMed ID: 10383772 [TBL] [Abstract][Full Text] [Related]
20. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. Cáceres-Ríos H; Rueda M; Ballona R; Bustamante B J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):80-4. PubMed ID: 10607324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]